Results 51 to 60 of about 8,090,991 (304)

Low-Loss Plasmonic Metamaterials

open access: yesScience, 2011
New materials are being developed that meet the requirements for nanoscale photonics.
Boltasseva, Alexandra, Atwater, Harry A.
openaire   +3 more sources

Implementation of low-loss superinductances for quantum circuits

open access: yes, 2012
The simultaneous suppression of charge fluctuations and offsets is crucial for preserving quantum coherence in devices exploiting large quantum fluctuations of the superconducting phase. This requires an environment with both extremely low DC and high RF
Archana Kamal   +5 more
core   +1 more source

Ultralow Loss, High Q, Four Port Resonant Couplers for Quantum Optics and Photonics [PDF]

open access: yes, 2004
We demonstrate a low-loss, optical four port resonant coupler (add-drop geometry), using ultrahigh Q (>108) toroidal microcavities. Different regimes of operation are investigated by variation of coupling between resonator and fiber taper waveguides.
Rokhsari, H., Vahala, K. J.
core   +1 more source

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

A Dual-Band Bandpass Filter with Wide Upper Stopband Using Stepped-Impedance Resonators and an Integrated Low-Pass Filter

open access: yesMicromachines
In this paper, a dual-band bandpass filter with a wide upper stopband is proposed and designed by integrating stepped-impedance resonators (SIRs) and a low-pass filter. The operating center frequencies of the designed dual-band filter are targeted at 2.5
Liqin Liu   +4 more
doaj   +1 more source

A Performance Optimized CSTBT with Low Switching Loss

open access: yesMicromachines, 2023
A novel Performance Optimized Carrier Stored Trench Gate Bipolar Transistor (CSTBT) with Low Switching Loss has been proposed. By applying a positive DC voltage to the shield gate, the carrier storage effect is enhanced, the hole blocking capability is ...
Hang Xu   +4 more
doaj   +1 more source

Low-optical-loss, low-resistance Ag/Ge based ohmic contacts to n-type InP for membrane based waveguide devices [PDF]

open access: yes, 2015
We present the development of Ag/Ge based ohmic contacts to n-type InP with both low contact resistances and relatively low optical losses. A specific contact resistance as low as 1.5×10-6 O cm2 is achieved by optimizing the Ge layer thickness and ...
Ambrosius, HPMM   +10 more
core   +2 more sources

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

Preparation of low-permittivity K2O–B2O3–SiO2–Al2O3 composites without the addition of glass

open access: yesNanotechnology Reviews, 2019
In the field of low temperature co-fired ceramic (LTCC), it remains a challenge to design the performance of LTCC with low permittivity less than 5. Here, the K2O– B2O3–SiO2–Al2O3 composites are prepared without the preparation of prior glass. Meanwhile,
Shang Yong   +6 more
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy